Phase 1 study of the PSMA-targeted small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Morris, M.; Vogelzang, N. J.; Sartor, O.; Armour, A.; Groaning, M.; Messmann, R.; Robarts, A.; Petrylak, D. P.; Tolcher, A.; Gordon, M. S.; Babiker, H. |
| Abstract Title: | Phase 1 study of the PSMA-targeted small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC) |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx370.010 |
| Language: | English |
| ACCESSION: | WOS:000411324001309 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx370.010 |
| Notes: | Meeting Abstract: 793PD -- Appears on page 273 of the abstract book -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
